- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.10. | AbbVie taps Tyler James Williams to go 'Beyond a Gut Feeling' in new IBD campaign | ||
| 07.10. | OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M | ||
| 06.10. | Biogen told to pay $124M in patent dispute with Genentech | ||
| 06.10. | Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India | ||
| 06.10. | Amgen unveils DTC platform with 60% discount on Repatha, giving US lowest price of G7 nations | ||
| 06.10. | AstraZeneca, Daiichi score 'landmark' results for ADC Datroway in triple-negative breast cancer | ||
| 06.10. | Myeloid Therapeutics creates new identity after pipeline outgrows its name | ||
| 03.10. | FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing | ||
| 03.10. | Big Pharma's 'Brexit' draws call for anticompetition probe from advocacy groups: report | ||
| 03.10. | 4 reasons why life sciences still fail women at the top, despite a female-majority workforce: report | ||
| 03.10. | Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate | ||
| 03.10. | With FDA approval, Jazz Pharma and Roche's combo sets new bar in first-line small cell lung cancer | ||
| 03.10. | GSK overturns UK watchdog's most serious sanction in COVID press release row | ||
| 02.10. | Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher's NC production facility | ||
| 02.10. | Amgen charts late-stage win for Repatha in broad cardiovascular risk population | ||
| 02.10. | Acadia, e-therapeutics unveil rebrands to better represent their drugmaking missions | ||
| 02.10. | Vanda and the FDA make nice, agreeing to squash several disputes following appeals court win | ||
| 02.10. | AbbVie, BeOne end BTK blood cancer drug patent fight | ||
| 02.10. | Ansa snares $54.4M in series B financing to boost its DNA synthesis platform | ||
| 02.10. | Regulatory tracker: J&J's Tremfya picks up 2 pediatric approvals from FDA | ||
| 01.10. | Halozyme buys subcutaneous drug delivery peer Elektrofi for up to $900M | ||
| 01.10. | Trump's pharma tariffs on hold amid administration's effort to secure pricing concessions, industry investment: Stat | ||
| 01.10. | FDA snubs Cyprium-Sentynl drug for rare pediatric disease due to manufacturing issues | ||
| 01.10. | FDA avoids the worst amid government shutdown, but new applications put on hold | ||
| 01.10. | AbbVie charts next leg of US investment journey with $70M expansion in Mass. |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .